WEDNESDAY, Jan. 26, 2022 (HealthDay News) — Belly fat is usually unwelcome, but new research suggests it may actually be good for something: relief from foot pain. A small pilot study suggests that an injection of a patient’s own fat cells can help ease the often-excruciating heel pain brought onContinue Reading

WEDNESDAY, Jan. 26, 2022 (HealthDay News) — Saline intravenous (IV) fluids are as effective as more costly solutions in treating intensive care patients and keeping them alive, Australian researchers report. “Just about every patient admitted to the intensive care unit (ICU) will receive intravenous fluids for resuscitation or as partContinue Reading

TUESDAY, Jan. 25, 2022 (HealthDay News) — Pfizer Inc. announced Tuesday that it has launched a trial that will compare its existing COVID-19 vaccine against a new version tailored to beat back the highly contagious Omicron variant. “While current research and real-world data show that boosters continue to provide aContinue Reading

MONDAY, Jan. 24, 2022 (HealthDay News) — Cannabidiol, a compound derived from marijuana, appears to show promise in blocking replication of the COVID-19 virus and preventing its spread, lab and animal studies show. CBD inhibited the ability of the coronavirus to spread in human lung cell samples, and also suppressedContinue Reading

MONDAY, Jan. 24, 2022 (HealthDay News) — Coronavirus testing requirements for vaccinated people arriving in England will be scrapped, British Prime Minister Boris Johnson announced Monday. Details about the changes are to be provided later in the day by Transport Secretary Grant Shapps, the Associated Press reported. To “show thatContinue Reading

MONDAY, Jan. 24, 2022 (HealthDay News) — A brain implant that helps control severe epilepsy in adults may do the same for children who suffer from unrelenting seizures, new research suggests. The study is one of the first to examine the responsive neurostimulation (RNS) system in children. RNS has alreadyContinue Reading

FRIDAY, Jan. 21, 2022 (HealthDay News) — Some kids might be able to get over their peanut allergy if they start immunotherapy while they’re still toddlers, a major new clinical trial reports. In the trial, a group of 1- to 3-year-olds with severe peanut allergies were safely fed gradually increasingContinue Reading